Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Romano Danesi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Occupations

Pharmacogenetics

Physiology

Cell Division

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Fioravanti Anna; Canu Bastianina; Alì Greta; Orlandi Paola; Allegrini Giacomo; Di Desidero Teresa; Emmenegger Urban; Fontanini Gabriella; Danesi Romano; Del Tacca Mario; Falcone Alfredo; Bocci Guido
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Crea Francesco; Giovannetti Elisa; Zinzani Pier Luigi; Danesi Romano
Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.
Jain Lokesh; Vargo Craig A; Danesi Romano; Sissung Tristan M; Price Douglas K; Venzon David; Venitz Jürgen; Figg William D
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Romano Danesi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fioravanti Anna; Canu Bastianina; Alì Greta; Orlandi Paola; Allegrini Giacomo; Di Desidero Teresa; Emmenegger Urban; Fontanini Gabriella; Danesi Romano; Del Tacca Mario; Falcone Alfredo; Bocci Guido
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
European journal of pharmacology 2009;619(1-3):8-14.
2009: Crea Francesco; Giovannetti Elisa; Zinzani Pier Luigi; Danesi Romano
Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.
Critical reviews in oncology/hematology 2009;72(1):21-44.
2009: Jain Lokesh; Vargo Craig A; Danesi Romano; Sissung Tristan M; Price Douglas K; Venzon David; Venitz Jürgen; Figg William D
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.
Molecular cancer therapeutics 2009;8(9):2496-508.
2009: Consoli Giorgio; Lastella Marianna; Ciapparelli Antonio; Dell'Osso Mario Catena; Ciofi Laura; Guidotti Emanuele; Danesi Romano; Dell'Osso Liliana; Del Tacca Mario; Di Paolo Antonello
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
Pharmacogenomics 2009;10(8):1267-76.
2009: Coltelli Luigi; Allegrini Giacomo; Orlandi Paola; Giuntini Nicola; Alì Greta; Fioravanti Anna; Bona Eleonora; Barletta Maria Teresa; Fontanini Gabriella; Del Tacca Mario; Danesi Romano; Falcone Alfredo; Bocci Guido
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis.
Pharmacogenomics 2009;10(8):1225-9.
2009: Fontana Andrea; Galli Luca; Fioravanti Anna; Orlandi Paola; Galli Costanza; Landi Lorenza; Bursi Simona; Allegrini Giacomo; Fontana Eloise; Di Marsico Roberta; Antonuzzo Andrea; D'Arcangelo Manolo; Danesi Romano; Del Tacca Mario; Falcone Alfredo; Bocci Guido
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(15):4954-62.
2009: Crea Francesco; Giovannetti Elisa; Cortesi Filippo; Mey Valentina; Nannizzi Sara; Gallegos Ruiz Marielle I; Ricciardi Simona; Del Tacca Mario; Peters Godefridus J; Danesi Romano
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
Molecular cancer therapeutics 2009;8(7):1964-73.
2009: Pacetti Paola; Giovannetti Elisa; Mambrini Andrea; Nannizzi Sara; Orlandi Massimo; Tartarini Roberta; Del Freo Alfonso; Del Tacca Mario; Danesi Romano; Cantore Maurizio
Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.
Anticancer research 2009;29(5):1835-40.
2009: Danesi Romano; Pasqualetti Giuseppe; Giovannetti Elisa; Crea Francesco; Altavilla Giuseppe; Del Tacca Mario; Rosell Rafael
Pharmacogenomics in non-small-cell lung cancer chemotherapy.
Advanced drug delivery reviews 2009;61(5):408-17.
2009: Danesi Romano; Altavilla Giuseppe; Giovannetti Elisa; Rosell Raffael
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors.
Pharmacogenomics 2009;10(1):69-80.
2008: Brandi Giovanni; de Rosa Francesco; Danesi Romano; Montini Gian Carlo; Biasco Guido
Durable complete response to frontline docetaxel in an advanced prostate cancer patient with favourable CYP1B1 isoforms: suggestion for changing paradigms?
European urology 2008;54(4):938-41.
2008: Sharifi Nima; Hamada Akinobu; Sissung Tristan; Danesi Romano; Venzon David; Baum Caitlin; Gulley James L; Price Douglas K; Dahut William L; Figg William D
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer.
BJU international 2008;102(5):617-21.
2008: Funel Niccola; Giovannetti Elisa; Del Chiaro Marco; Mey Valentina; Pollina Luca E; Nannizzi Sara; Boggi Ugo; Ricciardi Simona; Del Tacca Mario; Bevilacqua Generoso; Mosca Franco; Danesi Romano; Campani Daniela
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.
Laboratory investigation; a journal of technical methods and pathology 2008;88(7):773-84.
2008: Giovannetti E; Laan A C; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters G J
Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Nucleosides, nucleotides & nucleic acids 2008;27(6):720-5.
2008: Hamada Akinobu; Sissung Tristan; Price Douglas K; Danesi Romano; Chau Cindy H; Sharifi Nima; Venzon David; Maeda Kenji; Nagao Keisuke; Sparreboom Alex; Mitsuya Hiroaki; Dahut William L; Figg William D
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3312-8.
2008: Di Paolo Antonello; Lencioni Monica; Amatori Federica; Di Donato Samantha; Bocci Guido; Orlandini Cinzia; Lastella Marianna; Federici Francesca; Iannopollo Mauro; Falcone Alfredo; Ricci Sergio; Del Tacca Mario; Danesi Romano
5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2749-55.
2008: Bocci G; Falcone A; Fioravanti A; Orlandi P; Di Paolo A; Fanelli G; Viacava P; Naccarato A G; Kerbel R S; Danesi R; Del Tacca M; Allegrini G
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib.
British journal of cancer 2008;98(10):1619-29.
2008: Allegrini G; Falcone A; Fioravanti A; Barletta M T; Orlandi P; Loupakis F; Cerri E; Masi G; Di Paolo A; Kerbel R S; Danesi R; Del Tacca M; Bocci G
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.
British journal of cancer 2008;98(8):1312-9.
2008: Giovannetti Elisa; Lemos Clara; Tekle Christina; Smid Kees; Nannizzi Sara; Rodriguez José A; Ricciardi Simona; Danesi Romano; Giaccone Giuseppe; Peters Godefridus J
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
Molecular pharmacology 2008;73(4):1290-300.
2008: Tibaldi Carmelo; Giovannetti Elisa; Vasile Enrico; Mey Valentina; Laan Adrie C; Nannizzi Sara; Di Marsico Roberta; Antonuzzo Andrea; Orlandini Cinzia; Ricciardi Simona; Del Tacca Mario; Peters Godefridus J; Falcone Alfredo; Danesi Romano
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1797-803.
2007: Bocci G; Culler M D; Fioravanti A; Orlandi P; Fasciani A; Colucci R; Taylor J E; Sadat D; Danesi R; Del Tacca M
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists.
European journal of clinical investigation 2007;37(9):700-8.
2007: Danesi Romano; Pasqualetti Giuseppe; Giovannetti Elisa; Del Tacca Mario
The role of pharmacogenetics in adjuvant treatment of non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5 Suppl):S27-30.
2007: Giovannetti Elisa; Mey Valentina; Loni Lucia; Nannizzi Sara; Barsanti Gemma; Savarino Grazia; Ricciardi Simona; Del Tacca Mario; Danesi Romano
Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 2007;55(4):343-9.
2007: Pasqualetti Giuseppe; Danesi Romano; Del Tacca Mario; Bocci Guido
Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.
Pharmacogenomics 2007;8(1):49-66.
2006: Bianco Cataldo; Giovannetti Elisa; Ciardiello Fortunato; Mey Valentina; Nannizzi Sara; Tortora Giampaolo; Troiani Teresa; Pasqualetti Francesco; Eckhardt Gail; de Liguoro Mario; Ricciardi Simona; Del Tacca Mario; Raben David; Cionini Luca; Danesi Romano
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7099-107.
2006: Amatori Federica; Di Paolo Antonello; Del Tacca Mario; Fontanini Gabriella; Vannozzi Francesca; Boldrini Laura; Bocci Guido; Lastella Marianna; Danesi Romano
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
Pharmacogenetics and genomics 2006;16(11):809-16.
2006: Barbara Cecilia; Orlandi Paola; Bocci Guido; Fioravanti Anna; Di Paolo Antonello; Natale Gianfranco; Del Tacca Mario; Danesi Romano
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
European journal of pharmacology 2006;549(1-3):27-34.
2006: Allegrini Giacomo; Di Paolo Antonello; Cerri Elisa; Cupini Samanta; Amatori Federica; Masi Gianluca; Danesi Romano; Marcucci Lorenzo; Bocci Guido; Del Tacca Mario; Falcone Alfredo
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
Cancer chemotherapy and pharmacology 2006;58(5):585-93.
2006: Bocci Guido; Barbara Cecilia; Vannozzi Francesca; Di Paolo Antonello; Melosi Alessandro; Barsanti Gemma; Allegrini Giacomo; Falcone Alfredo; Del Tacca Mario; Danesi Romano
A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Clinical pharmacology and therapeutics 2006;80(4):384-95.
2006: Di Paolo Antonello; Bocci Guido; Danesi Romano; Del Tacca Mario
Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.
Current clinical pharmacology 2006;1(3):311-23.
2006: Mey V; Giovannetti E; De Braud F; Nannizzi S; Curigliano G; Verweij F; De Cobelli O; Pece S; Del Tacca M; Danesi R
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
British journal of cancer 2006;95(3):289-97.
2006: Giovannetti Elisa; Mey Valentina; Nannizzi Sara; Pasqualetti Giuseppe; Del Tacca Mario; Danesi Romano
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.
Molecular cancer therapeutics 2006;5(6):1387-95.
2006: Giovannetti E; Danesi R; Mey V; Nannizzi S; Pasqualetti G; Del Tacca M
In vitro studies on gemcitabine combinations with other antiblastics.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v17-19.
2006: Giovannetti Elisa; Del Tacca Mario; Mey Valentina; Funel Niccola; Nannizzi Sara; Ricci Sergio; Orlandini Cinzia; Boggi Ugo; Campani Daniela; Del Chiaro Marco; Iannopollo Mauro; Bevilacqua Generoso; Mosca Franco; Danesi Romano
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.
Cancer research 2006;66(7):3928-35.
2006: Minutolo Filippo; Bertini Simone; Betti Laura; Danesi Romano; Gervasi Gianbattista; Giannaccini Gino; Martinelli Adriano; Papini Anna Maria; Peroni Elisa; Placanica Giorgio; Rapposelli Simona; Tuccinardi Tiziano; Macchia Marco
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition.
ChemMedChem 2006;1(2):218-24.
2005: Orlandi P; Barbara C; Bocci G; Fioravanti A; Di Paolo A; Del Tacca M; Danesi R
Idarubicin and idarubicinol effects on breast cancer multicellular spheroids.
Journal of chemotherapy (Florence, Italy) 2005;17(6):663-7.
2005: Bocci G; Fioravanti A; Orlandi P; Bernardini N; Collecchi P; Del Tacca M; Danesi R
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
British journal of cancer 2005;93(3):319-30.
2005: Bengala C; Guarneri V; Giovannetti E; Lencioni M; Fontana E; Mey V; Fontana A; Boggi U; Del Chiaro M; Danesi R; Ricci S; Mosca F; Del Tacca M; Conte P F
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.
British journal of cancer 2005;93(1):35-40.
2005: Giovannetti Elisa; Mey Valentina; Nannizzi Sara; Pasqualetti Giuseppe; Marini Luca; Del Tacca Mario; Danesi Romano
Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.
Molecular pharmacology 2005;68(1):110-8.
2005: Di Paolo Antonello; Danesi Romano; Ciofi Laura; Vannozzi Francesca; Bocci Guido; Lastella Marianna; Amatori Federica; Martelloni Bianca Maria; Ibrahim Toni; Amadori Dino; Falcone Alfredo; Del Tacca Mario
Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling.
Therapeutic drug monitoring 2005;27(3):362-8.
2005: Minutolo Filippo; Asso Valentina; Bertini Simone; Betti Laura; Ciriaco Massimiliano; Danesi Romano; Gervasi Gianbattista; Ghilardi Elisa; Giovanetti Elisa; Giannaccini Gino; Placanica Giorgio; Prota Giovanni; Rapposelli Simona; Macchia Marco
Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents.
Medicinal chemistry (Shariqah (United Arab Emirates)) 2005;1(3):239-44.
2005: Boggi Ugo; Vistoli Fabio; Signori Stefano; Del Chiaro Marco; Amorese Gabriella; Barsotti Massimiliano; Rizzo Gaetano; Marchetti Piero; Danesi Romano; Del Tacca Mario; Mosca Franco
Efficacy and safety of basiliximab in kidney transplantation.
Expert opinion on drug safety 2005;4(3):473-90.
2005: Innocenti Federico; Danesi Romano; Bocci Guido; Natale Gianfranco; Del Tacca Mario
5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice.
Toxicology and applied pharmacology 2005;203(2):106-13.
2005: Giovannetti E; Mey V; Danesi R; Basolo F; Barachini S; Deri M; Del Tacca M
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.
British journal of cancer 2005;92(4):681-9.
2005: Danesi Romano; Bocci Guido; Di Paolo Antonello
Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens.
Clinical colorectal cancer 2005;4(5):344.
2004: De Pas Tommaso; Pelosi Giuseppe; de Braud Filippo; Veronesi Giulia; Curigliano Giuseppe; Leon Maria Elena; Danesi Romano; Noberasco Cristina; d'Aiuto Massimiliano; Catalano Gianpiero; Viale Giuseppe; Spaggiari Lorenzo
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4966-70.
2004: Vannozzi F; Filipponi F; Di Paolo A; Danesi R; Urbani L; Bocci G; Catalano G; De Simone P; Mosca F; Del Tacca M
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients.
Transplantation proceedings 2004;36(9):2787-90.
2004: Danesi Romano; Amatori Federica; Di Paolo Antonello
Genetic determinants in the study of colorectal cancer.
Clinical colorectal cancer 2004;4(4):260-1.
2004: Minutolo Filippo; Antonello Michela; Barontini Silvia; Bertini Simone; Betti Laura; Danesi Romano; Gervasi Gianbattista; Giannaccini Gino; Papi Chiara; Placanica Giorgio; Rapposelli Simona; Macchia Marco
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors.
Farmaco (Società chimica italiana : 1989) 2004;59(11):887-92.
2004: Bocci Guido; Danesi Romano; Marangoni Gabriele; Fioravanti Anna; Boggi Ugo; Esposito Irene; Fasciani Alessandro; Boschi Elena; Campani Daniela; Bevilacqua Generoso; Mosca Franco; Del Tacca Mario
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.
European journal of pharmacology 2004;498(1-3):9-18.
2004: Giovannetti Elisa; Mey Valentina; Danesi Romano; Mosca Irene; Del Tacca Mario
Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2936-43.
2004: Di Paolo Antonello; Danesi Romano; Del Tacca Mario
Pharmacogenetics of neoplastic diseases: new trends.
Pharmacological research : the official journal of the Italian Pharmacological Society 2004;49(4):331-42.
2004: Danesi R; Del Tacca M
Teratogenesis and immunosuppressive treatment.
Transplantation proceedings 2004;36(3):705-7.
2004: Danesi R; Del Tacca M
Hematologic toxicity of immunosuppressive treatment.
Transplantation proceedings 2004;36(3):703-4.
2004: Masi Gianluca; Falcone Alfredo; Di Paolo Antonello; Allegrini Giacomo; Danesi Romano; Barbara Cecilia; Cupini Samanta; Del Tacca Mario
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1657-63.
2004: Danesi Romano; Bocci Guido; Di Paolo Antonello
Biologic basis of ovarian metastasis of colorectal cancer.
Clinical colorectal cancer 2004;3(4):223-4.
2004: Boggi Ugo; Danesi Romano; Vistoli Fabio; Del Chiaro Marco; Signori Stefano; Marchetti Piero; Del Tacca Mario; Mosca Franco
A benefit-risk assessment of basiliximab in renal transplantation.
Drug safety : an international journal of medical toxicology and drug experience 2004;27(2):91-106.
2003: Minutolo Filippo; Bertini Simone; Betti Laura; Danesi Romano; Gervasi Gianbattista; Giannaccini Gino; Papi Chiara; Placanica Giorgio; Barontini Silvia; Rapposelli Simona; Macchia Marco
Stable analogues of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity.
Bioorganic & medicinal chemistry letters 2003;13(24):4405-8.
2003: De Pas T; Danesi R; Catania C; Curigliano G; De Braud F;
Imatinib administration in two patients with liver metastases from GIST and severe jaundice.
British journal of cancer 2003;89(8):1403-4.
2003: Lupetti Antonella; Nibbering Peter H; Campa Mario; Del Tacca Mario; Danesi Romano
Molecular targeted treatments for fungal infections: the role of drug combinations.
Trends in molecular medicine 2003;9(6):269-76.
2003: Danesi Romano; Paolo Antonello Di
Impact of locoregional approaches to liver metastases in patients with colorectal cancer.
Clinical colorectal cancer 2003;3(1):45-6.
2003: Danesi Romano; Lupetti Antonella; Barbara Cecilia; Ghelardi Emilia; Chella Antonio; Malizia Tecla; Senesi Sonia; Angeletti Carlo Alberto; Del Tacca Mario; Campa Mario
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.
The Journal of antimicrobial chemotherapy 2003;51(4):939-45.
2003: Zucchi Riccardo; Danesi Romano
Cardiac toxicity of antineoplastic anthracyclines.
Current medicinal chemistry. Anti-cancer agents 2003;3(2):151-71.
2003: Macchia Marco; Bertini Simone; Fogli Stefano; Giovannetti Elisa; Minutolo Filippo; Rapposelli Simona; Danesi Romano
Ceramide analogues in apoptosis: a new strategy for anticancer drug development.
Farmaco (Società chimica italiana : 1989) 2003;58(3):205-11.
2003: Danesi Romano; de Braud Filippo; Fogli Stefano; de Pas Tommaso Martino; Di Paolo Antonello; Curigliano Giuseppe; Del Tacca Mario
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Pharmacological reviews 2003;55(1):57-103.
2003: Bengala C; Danesi R; Guarneri V; Pazzagli I; Donati S; Favre C; Fogli S; Biadi O; Innocenti F; Del Tacca M; Mariani M; Conte P F
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Bone marrow transplantation 2003;31(4):275-80.
2003: Danesi Romano; Paolo Antonello Di
Predicting survival with artificial neural networks.
Clinical colorectal cancer 2003;2(4):245.
2003: Macchia Marco; Antonello Michela; Bertini Simone; Di Bussolo Valeria; Fogli Stefano; Giovannetti Elisa; Minutolo Filippo; Rapposelli Simona; Danesi Romano
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity.
Farmaco (Società chimica italiana : 1989) 2003;58(1):85-9.
2003: Loni Lucia; De Braud Filippo; Zinzani Pier Luigi; Danesi Romano
Pharmacogenetics and proteomics of anticancer drugs in non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44 Suppl 3():S115-22.
2002: Di Paolo Antonello; Danesi Romano; Vannozzi Francesca; Falcone Alfredo; Mini Enrico; Cionini Luca; Ibrahim Toni; Amadori Dino; Del Tacca Mario
Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
Clinical pharmacology and therapeutics 2002;72(6):627-37.
2002: Di Paolo Antonello; Ibrahim Toni; Danesi Romano; Maltoni Marco; Vannozzi Francesca; Flamini Emanuela; Zoli Wainer; Amadori Dino; Del Tacca Mario
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients.
Therapeutic drug monitoring 2002;24(5):588-93.
2002: Falcone Alfredo; Masi Gianluca; Allegrini Giacomo; Danesi Romano; Pfanner Elisabetta; Brunetti Isa Maura; Di Paolo Antonello; Cupini Samanta; Del Tacca Mario; Conte Pierfranco
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4006-14.
2002: Danesi Romano; Di Paolo Antonello
Irinotecan in 5-fluorouracil-refractory colorectal cancer.
Clinical colorectal cancer 2002;2(2):102-3.
2002: Fogli S; Danesi R; Gennari A; Donati S; Conte P F; Del Tacca M
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):919-27.
2002: Danesi Romano; Innocenti Federico; Fogli Stefano; Gennari Alessandra; Baldini Editta; Di Paolo Antonello; Salvadori Barbara; Bocci Guido; Conte Pier Franco; Del Tacca Mario
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
British journal of clinical pharmacology 2002;53(5):508-18.
2002: Blandizzi Corrado; Danesi Romano; De Paolis Barbara; Di Paolo Antonello; Colucci Rocchina; Falcone Alfredo; Del Tacca Mario
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.
Clinical pharmacology and therapeutics 2002;71(4):263-71.
2002: Lupetti Antonella; Danesi Romano; Campa Mario; Del Tacca Mario; Kelly Steven
Molecular basis of resistance to azole antifungals.
Trends in molecular medicine 2002;8(2):76-81.
2002: Bocci Guido; Danesi Romano; Fioravanti Anna; Del Tacca Mario
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;45(1):21-5.
2002: Danesi Romano; Fogli Stefano; Gennari Alessandra; Conte Pierfranco; Del Tacca Mario
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.
Clinical pharmacokinetics 2002;41(6):431-44.
2001: Blandizzi C; De Paolis B; Colucci R; Di Paolo A; Danesi R; Del Tacca M
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study.
Toxicology and applied pharmacology 2001;177(2):149-56.
2001: Fogli S; Danesi R; De Braud F; De Pas T; Curigliano G; Giovannetti G; Del Tacca M
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1553-9.
2001: Loni L; Del Tacca M; Danesi R
Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas.
British journal of cancer 2001;85(10):1425-31.
2001: Macchia M; Barontini S; Bertini S; Di Bussolo V; Fogli S; Giovannetti E; Grossi E; Minutolo F; Danesi R
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues.
Journal of medicinal chemistry 2001;44(23):3994-4000.
2001: Di Paolo A; Danesi R; Falcone A; Cionini L; Vannozzi F; Masi G; Allegrini G; Mini E; Bocci G; Conte P F; Del Tacca M
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1301-6.
2001: Falcone A; Di Paolo A; Masi G; Allegrini G; Danesi R; Lencioni M; Pfanner E; Comis S; Del Tacca M; Conte P
Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3456-62.
2001: Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Trends in pharmacological sciences 2001;22(8):420-6.
2001: Bocci G; Fasciani A; Danesi R; Viacava P; Genazzani A R; Del Tacca M
In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels.
Molecular human reproduction 2001;7(8):771-7.
2001: Conte P F; Gennari A; Donati S; Salvadori B; Baldini E; Bengala C; Pazzagli I; Orlandini C; Danesi R; Fogli S; Del Tacca M
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
Breast cancer research and treatment 2001;68(2):171-9.
2001: Di Paolo A; Danesi R; Caputo S; Macchia M; Lastella M; Boggi U; Mosca F; Marchetti A; Del Tacca M
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.
British journal of cancer 2001;84(11):1535-43.
2001: Bengala C; Pazzagli I; Innocenti F; Donati S; Favre C; Menconi M C; Greco F; Danesi R; Orlandini C; Guarneri V; Del Tacca M; Conte P F
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):69-74.
2001: Falcone A; Allegrini G; Masi G; Lencioni M; Pfanner E; Brunetti I; Danesi R; Bocci G; Del Tacca M; Conte P
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.
Oncology 2001;61(1):28-35.
2000: Bocci G; Danesi R; Di Paolo A D; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte P F; Del Tacca M
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3032-7.
2000: Innocenti F; Danesi R; Favre C; Nardi M; Menconi M C; Di Paolo A; Bocci G; Fogli S; Barbara C; Barachini S; Casazza G; Macchia P; Del Tacca M
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia.
Therapeutic drug monitoring 2000;22(4):375-82.
2000: Collecchi P; Santoni T; Gnesi E; Giuseppe Naccarato A; Passoni A; Rocchetta M; Danesi R; Bevilacqua G
Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas.
Cytometry 2000;42(4):254-60.
2000: De Pas T; de Braud F; Danesi R; Sessa C; Catania C; Curigliano G; Fogli S; del Tacca M; Zampino G; Sbanotto A; Rocca A; Cinieri S; Marrocco E; Milani A; Goldhirsch A
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):821-7.
2000: Di Paolo A; Danesi R; Nardini D; Bocci G; Innocenti F; Fogli S; Barachini S; Marchetti A; Bevilacqua G; Del Tacca M
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.
British journal of cancer 2000;82(4):905-12.
2000: Gennari A; Donati S; Danesi R; Fogli S; Orlandini C; Del Tacca M; Conte P F
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer.
Seminars in oncology 2000;27(1 Suppl 2):14-9.
1999: Del Tacca M; Di Paolo A; Danesi R
[Preclinical pharmacology and clinical uses of topotecan]
Tumori 1999;85(6 Suppl 1):S3-11.
1999: Gennari A; Salvadori B; Donati S; Bengala C; Orlandini C; Danesi R; Del Tacca M; Bruzzi P; Conte P F
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3596-602.
1999: Falcone A; Allegrini G; Antonuzzo A; Brunetti I; Pfanner E; Lencioni M; Masi G; Danesi R; Del Tacca M; Conte P
Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug delivery.
Oncology 1999;57(3):195-201.
1999: Danesi R; Conte P F; Del Tacca M
Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.
Clinical pharmacokinetics 1999;37(3):195-211.
1999: Falcone A; Antonuzzo A; Danesi R; Allegrini G; Monica L; Pfanner E; Masi G; Ricci S; Del Tacca M; Conte P
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma.
Cancer 1999;86(3):470-6.
1999: Fogli S; Danesi R; Innocenti F; Di Paolo A; Bocci G; Barbara C; Del Tacca M
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
Therapeutic drug monitoring 1999;21(3):367-75.
1999: Innocenti F; Danesi R; Bocci G; Fogli S; Di Paolo A; Del Tacca M
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.
Cancer chemotherapy and pharmacology 1999;43(2):133-40.
1999: Bocci G; Danesi R; Benelli U; Innocenti F; Di Paolo A; Fogli S; Del Tacca M
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo.
Cancer chemotherapy and pharmacology 1999;43(3):205-12.
1998: Falcone A; Pfanner E; Brunetti I; Allegrini G; Lencioni M; Galli C; Masi G; Danesi R; Antonuzzo A; Del Tacca M; Conte P F
Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy.
Tumori 1998;84(6):666-8.
1998: Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
Experimental eye research 1998;67(2):133-42.
1998: Gesi M; Pellegrini A; Soldani P; Lenzi P; Paparelli A; Danesi R; Nardini D; Macchia M
Ultrastructural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA PaCa-2 pancreatic cancer cells.
Ultrastructural pathology 1998;22(3):253-61.
1997: Malizia T; Tejada M R; Ghelardi E; Senesi S; Gabriele M; Giuca M R; Blandizzi C; Danesi R; Campa M; Del Tacca M
Periodontal tissue disposition of azithromycin.
Journal of periodontology 1997;68(12):1206-9.
1997: Di Paolo A; Danesi R; Innocenti F; Bocci G; Nardini D; Fogli S; Pollina L; Rossi B; Del Tacca M
Chronic administration of suramin induces neurotoxicity in rats.
Journal of the neurological sciences 1997;152(2):125-31.
1997: Conte P F; Baldini E; Gennari A; Michelotti A; Salvadori B; Tibaldi C; Danesi R; Innocenti F; Gentile A; Dell'Anna R; Biadi O; Mariani M; Del Tacca M
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2510-7.
1997: Falcone A; Lencioni M; Brunetti I; Pfanner E; Allegrini G; Antonuzzo A; Andreuccetti M; Malvaldi G; Danesi R; Del Tacca M; Conte P F
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):539-45.
1997: Danesi R; Agen C; Benelli U; Paolo A D; Nardini D; Bocci G; Basolo F; Campagni A; Tacca M D
Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):265-72.
1996: Danesi R; Del Tacca M
The effects of the somatostatin analog octreotide on angiogenesis in vitro.
Metabolism: clinical and experimental 1996;45(8 Suppl 1):49-50.
1996: Danesi R; La Rocca R V; Cooper M R; Ricciardi M P; Pellegrini A; Soldani P; Kragel P J; Paparelli A; Del Tacca M; Myers C E
Clinical and experimental evidence of inhibition of testosterone production by suramin.
The Journal of clinical endocrinology and metabolism 1996;81(6):2238-46.
1996: Andreuccetti M; Allegrini G; Antonuzzo A; Malvaldi G; Conte P F; Danesi R; Del Tacca M; Falcone A
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1219-26.
1996: Danesi R; Nardini D; Basolo F; Del Tacca M; Samid D; Myers C E
Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
Molecular pharmacology 1996;49(6):972-9.
1996: Macchia M; Jannitti N; Gervasi G; Danesi R
Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
Journal of medicinal chemistry 1996;39(7):1352-6.
1996: Falcone A; Danesi R; Dargenio F; Pfanner E; Brunetti I; Del Tacca M; Nethersell A B; Conte P F
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):729-36.
1996: Innocenti F; Danesi R; Di Paolo A; Loru B; Favre C; Nardi M; Bocci G; Nardini D; Macchia P; Del Tacca M
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.
Cancer chemotherapy and pharmacology 1996;37(5):409-14.
1995: di Paolo A; Bocci G; Innocenti F; Agen C; Nardini D; Danesi R; del Tacca M
Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines.
Pharmacological research : the official journal of the Italian Pharmacological Society 1995;32(3):135-9.
1995: Innocenti F; Danesi R; Di Paolo A; Agen C; Nardini D; Bocci G; Del Tacca M
Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.
Drug metabolism and disposition: the biological fate of chemicals 1995;23(7):713-7.
1995: Falcone A; Pfanner E; Cianci C; Danesi R; Brunetti I; Del Tacca M; Conte P F
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study.
Cancer 1995;75(2):440-3.
1995: Benelli U; Lepri A; Nardi M; Danesi R; Del Tacca M
Trapidil inhibits endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane and in the rat cornea.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1995;11(2):157-66.
1994: Costa M; Danesi R; Agen C; Di Paolo A; Basolo F; Del Bianchi S; Del Tacca M
MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery.
Cancer research 1994;54(1):9-11.
1994: Lepri A; Benelli U; Bernardini N; Bianchi F; Lupetti M; Danesi R; Del Tacca M; Nardi M
Effect of low molecular weight heparan sulphate on angiogenesis in the rat cornea after chemical cauterization.
Journal of ocular pharmacology 1994;10(1):273-80.
1994: Falcone A; Danesi R; Zaccaro L; Pieracci D; Pfanner E; Cianci C; Andreuccetti M; Malvaldi G; Del Tacca M; Conte P F
Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies.
European journal of cancer (Oxford, England : 1990) 1994;30A(4):516-20.
1994: Pinna A; Agen C; Di Paolo A; Innocenti F; Nardini D; Danesi R; Del Tacca M
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 1994;13(1):25-31.
1993: Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca R V; Myers C E; Paparelli A; Del Tacca M
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
British journal of cancer 1993;68(5):932-8.
1993: Bernardini N; Giannessi F; Bianchi F; Dolfi A; Lupetti M; Citti L; Danesi R; Del Tacca M
Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.
British journal of cancer 1993;67(6):1209-16.
1993: Agen C; Danesi R; Blandizzi C; Costa M; Stacchini B; Favini P; Del Tacca M
Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role.
Agents and actions 1993;38(1-2):85-90.
1993: Danesi R; Agen C; Grandi M; Nardini V; Bevilacqua G; Del Tacca M
3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity.
European journal of cancer (Oxford, England : 1990) 1993;29A(11):1560-5.
1992: Zolfino I; Senesi S; Campa M; Di Vito A; Mosca F; Favini P; Ducci M; Danesi R; Del Tacca M
Human skin disposition of cefpodoxime after oral administration of its proxetil ester.
The Journal of antimicrobial chemotherapy 1992;30(5):731-3.
1992: Agen C; Sironi A M; Danesi R; Costa M; Bernardini N; Paparelli A; Della Torre P; Del Tacca M
Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart.
Toxicology 1992;75(3):209-19.
1992: Soldani P; Danesi R; Ricciardi M P; Pellegrini A; Natale G; Paparelli A
Morphohistochemical characterization of suramin--induced chronic toxicity in rat kidney.
In vivo (Athens, Greece) 1992;6(6):617-20.
1992: Carobbi A; Di Stefano R; Danesi R; Carmellini M; Ferrari M; Galatioto C; Ermini M; Mosca F
Suramin as an anticomplementary agent in xenotransplantation.
Transplantation proceedings 1992;24(2):700.
1992: Agen C; Bernardini N; Blandizzi C; Danesi R; Del Tacca M
[The physiopathological aspects of the atrial natriuretic factor]
Minerva medica 1992;83(4):169-80.
1992: Bernardini N; Agen C; Favilla S; Danesi R; Del Tacca M
Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.
Journal of endocrinological investigation 1992;15(2):79-84.
1992: Danesi R; Agen C; Bernardini N; Costa M; Del Tacca M
The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF-beta 1).
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;25 Suppl 1():17-8.
1992: Agen C; Bernardini N; Danesi R; Della Torre P; Costa M; Del Tacca M
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Cancer chemotherapy and pharmacology 1992;30(2):95-9.
1992: Danesi R; Bernardini N; Agen C; Costa M; Zaccaro L; Pieracci D; Malvaldi G; Del Tacca M
Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.
Cancer chemotherapy and pharmacology 1992;29(4):261-5.
1991: Cini Neri G; Neri B; Bandinelli M; Del Tacca M; Danesi R; Riccardi R
Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat.
Oncology 1991;48(4):327-33.
1991: Danesi R; Bernardini N; Agen C; Costa M; Macchiarini P; Della Torre P; Del Tacca M
Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicin.
Toxicology 1991;70(2):243-53.
1990: Bernardini N; Danesi R; Del Tacca M
Changes of specific atrial granules induced by doxorubicin in dog's heart.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():37-8.
1990: Macchiarini P; Danesi R; Mariotti R; Marchetti A; Fazzi P; Bevilacqua G; Mariani M; Giuntini C; Del Tacca M; Angeletti C A
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer.
American journal of clinical oncology 1990;13(4):302-7.
1990: Campa M; Zolfino I; Senesi S; Bernardini N; Danesi R; Ducci M; Oleggini M; Di Stefano R; Mosca F; Lazzarini A
The penetration of roxithromycin into human skin.
The Journal of antimicrobial chemotherapy 1990;26(1):87-90.
1990: Danesi R; Marchetti A; Bernardini N; La Rocca R V; Bevilacqua G; Del Tacca M
Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.
Cancer chemotherapy and pharmacology 1990;26(6):403-8.
1990: Del Tacca M; Danesi R; Bernardini N; Ducci M; Zolfino I; Senesi S; Panattoni E; Gabriele M; Marcucci M; Lazzarini A
Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients.
Chemotherapy 1990;36(5):332-6.
1989: Malvaldi G; Batoni G; Marelli P; Zolfino I; Senesi S; Danesi R; Campa M
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure.
Immunopharmacology 1989;18(2):81-8.
1988: Danesi R; Ducci M; Acerbi D; Del Tacca M
Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
Arzneimittel-Forschung 1988;38(1):129-31.
1988: Danesi R; Gasperini M; Senesi S; Freer G; Angeletti C A; Del Tacca M
A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay.
Drugs under experimental and clinical research 1988;14(1):39-43.
1987: Del Tacca M; Danesi R; Senesi S; Gasperini M; Mussi A; Angeletti C A
Penetration of clofoctol into human lung.
The Journal of antimicrobial chemotherapy 1987;19(5):679-83.
1986: Panattoni E; Marcucci M; Danesi R; Del Tacca M
[Clinical efficacy of clofoctol in treating odontogenic infections]
Minerva stomatologica 1986;35(11):1071-4.
1986: Alessandrì M G; Ducci M; Scalori V; Danesi R; Del Tacca M; Bernardini M C; Mazzanti L
The pharmacokinetic profile of clofoctol in rat plasma and tissues after oral and rectal administration.
Drugs under experimental and clinical research 1986;12(4):343-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Romano Danesi

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Concepts & Ideas

Occupations

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Romano Danesi (preview)

All Publications